These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8388343

  • 1. Arginine vasopressin and oxytocin effects in mouse pancreatic beta-cells. Receptors involved in stimulation of insulin release.
    Gao ZY, Henquin JC.
    Diabetes; 1993 Jun; 42(6):914-21. PubMed ID: 8388343
    [Abstract] [Full Text] [Related]

  • 2. Effect of AVP and oxytocin on insulin release: involvement of V1b receptors.
    Lee B, Yang C, Chen TH, al-Azawi N, Hsu WH.
    Am J Physiol; 1995 Dec; 269(6 Pt 1):E1095-100. PubMed ID: 8572202
    [Abstract] [Full Text] [Related]

  • 3. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
    Yibchok-anun S, Hsu WH.
    Life Sci; 1998 Dec; 63(21):1871-8. PubMed ID: 9825765
    [Abstract] [Full Text] [Related]

  • 4. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y, Hiroyama M, Sanbe A, Yamauchi J, Tsujimoto G, Tanoue A.
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [Abstract] [Full Text] [Related]

  • 5. Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas.
    Yibchok-Anun S, Cheng H, Heine PA, Hsu WH.
    Am J Physiol; 1999 Jul; 277(1):E56-62. PubMed ID: 10409128
    [Abstract] [Full Text] [Related]

  • 6. Molecular pharmacology of human vasopressin receptors.
    Thibonnier M, Conarty DM, Preston JA, Wilkins PL, Berti-Mattera LN, Mattera R.
    Adv Exp Med Biol; 1998 Jul; 449():251-76. PubMed ID: 10026814
    [Abstract] [Full Text] [Related]

  • 7. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, Tsujimoto G.
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [Abstract] [Full Text] [Related]

  • 8. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
    Richardson SB, Laya T, VanOoy M.
    J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
    [Abstract] [Full Text] [Related]

  • 9. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
    Watanabe T, Oki Y, Orth DN.
    Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin.
    Manning M, Sawyer WH.
    J Recept Res; 1993 Oct; 13(1-4):195-214. PubMed ID: 8383753
    [Abstract] [Full Text] [Related]

  • 11. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
    Poulin P, Pittman QJ.
    J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
    [Abstract] [Full Text] [Related]

  • 12. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G.
    Prog Brain Res; 2008 Feb; 170():473-512. PubMed ID: 18655903
    [Abstract] [Full Text] [Related]

  • 13. Oxytocin at physiological concentrations evokes adrenocorticotropin (ACTH) release from corticotrophs by increasing intracellular free calcium mobilized mainly from intracellular stores. Oxytocin displays synergistic or additive effects on ACTH-releasing factor or arginine vasopressin-induced ACTH secretion, respectively.
    Link H, Dayanithi G, Föhr KJ, Gratzl M.
    Endocrinology; 1992 Apr; 130(4):2183-91. PubMed ID: 1312449
    [Abstract] [Full Text] [Related]

  • 14. Oxytocin- and vasopressin-binding sites in the rat uterus: competition binding and inhibitory pA2 studies with oxytocin and oxytocin antagonists.
    Chan WY, Cao L, Hill PS, Hruby VJ.
    Endocrinology; 1990 Apr; 126(4):2095-101. PubMed ID: 2318158
    [Abstract] [Full Text] [Related]

  • 15. Activation of oxytocin receptors, but not arginine-vasopressin V1a receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions.
    Song Z, Borland JM, Larkin TE, O'Malley M, Albers HE.
    Psychoneuroendocrinology; 2016 Dec; 74():164-172. PubMed ID: 27632574
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.
    Maggi M, Del Carlo P, Fantoni G, Giannini S, Torrisi C, Casparis D, Massi G, Serio M.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1142-54. PubMed ID: 2156888
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.
    Pierce ML, French JA, Murray TF.
    Biomed Pharmacother; 2020 Jun; 126():110060. PubMed ID: 32145592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.